Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Galena Biopharma (GALE)

Add to Watchlists
Create an Alert
2.29 +0.21  +10.10% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD

Galena Biopharma News

Edit Sources
EQUITY ALERT: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important May 5, 2014 Class Action Deadline -- GALE
GlobeNewswire 04/22 17:06 ET

NEW YORK -- The Rosen Law Firm, P.A. today reminds all purchasers of the common stock of Galena Biopharma, Inc. between November 6, 2013 and February 14, 2014, inclusive of the important May 5, 2014 lead ...

INVESTOR ALERT: Law Offices of Howard G. Smith Announces an Expanded Class Period in the Shareholder Lawsuit against Galena Biopharma, Inc.
Business Wire 04/22 10:32 ET

Law Offices of Howard G. Smith announces that the class action lawsuit against Galena Biopharma, Inc. filed in the United States District

Hagens Berman: Galena Biopharma Investigation Proceeds in Light of May 5, 2014 Lead Plaintiff Deadline in Securities Fraud Class Actions
PR Newswire 04/16 19:56 ET

SAN FRANCISCO, April 16, 2014 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP an investor-rights law firm with offices in San Francisco has intensified its investigation on behalf of Galena Biopharma, Inc. (GALE) ("Galena" or "the Company") in light of the May 5, 2014 deadline to file for lead plaintiff in the securities fraud cases against the company. Investors who purchased Galena stock between May 9, 2013 and March 17, 2014 (the "Class Period") can contact Hagens Berman Partner Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000, emailing Galena@hbsslaw.com or visiting http://hb-securities.com/investigations/Galena. The complaints, which were filed in the U.S. District Court for the District of Oregon, will likely be consolidated into one class action upon appointment of the lead plaintiff, and generally allege that unbeknownst to investors, Galena hired The DreamTeam Group and Mission IR, two affiliated promotional agents, to inflate the value of Galena common stock during the Class Period.

Lieff Cabraser Reminds Galena Biopharma, Inc. Investors of Upcoming Deadline in Class Action Litigation – GALE
Business Wire 04/11 18:28 ET

Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the May 5, 2014 deadline to move for appointment as lead plaintiff in the securities class litigation brought on behalf of those who purchased or otherwise acquired the securities of Galena Biopharma, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Galena Biopharma, Inc. and Certain Officers - GALE
PR Newswire 04/11 16:14 ET

NEW YORK, April 11, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against Galena Biopharma, Inc. ("Galena" or the "Company")(GALE) and certain of its officers. The class action, filed in United States District Court, District of Oregon, and docketed under 3:14-cv-00410-HZ, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Galena securities between March 12, 2013 and February 11, 2014, both dates inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. If you are a shareholder who purchased Galena securities during the Class Period, you have until May 5, 2014 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237.

GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against GALENA BIOPHARMA, INC. and Its Board and a Lead Plaintiff Deadline of May 5, 2014 -- GALE
Business Wire 04/10 12:15 ET

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Galena Biopharma, Inc. to Contact Brower Piven Before the May 5, 2014 Lead Plaintiff Deadline
Business Wire 04/09 17:14 ET

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of purchasers of Galena Biopharma, Inc.

Hagens Berman Notifies Investors of Extended Class Period and May 5, 2014 Lead Plaintiff Deadline in Galena Biopharma, Inc. Securities Fraud Class Actions
PR Newswire 04/07 17:23 ET

BERKELEY, Calif., April 7, 2014 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP reminds investors of the May 5, 2014 deadline to file for lead plaintiff in a securities fraud case against Galena Biopharma, Inc. (GALE) ("Galena" or "the Company"). The Class Period has been extended to cover investors who bought stock between May 9, 2013 and March 17, 2014 (the "Class Period"). Investors who purchased Galena securities during the Class Period may contact Hagens Berman Partner Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000, emailing Galena@hbsslaw.com or visiting http://hb-securities.com/investigations/Galena.

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Galena Biopharma, Inc.
Business Wire 04/03 13:03 ET

Glancy Binkow & Goldberg LLP reminds investors of Galena Biopharma, Inc. that all purchasers of Galena securities between November 6,

Galena Biopharma to Present at the 13th Annual Needham Healthcare Conference
GlobeNewswire 04/03 07:05 ET

PORTLAND, Ore. -- Galena Biopharma , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today ...

Hagens Berman Reminds Galena Biopharma, Inc. Investors of May 5, 2014, Lead Plaintiff Deadline and Continued Securities Fraud Investigation
Business Wire 03/31 13:37 ET

Hagens Berman Sobol Shapiro LLP reminds investors of the May 5, 2014, deadline to file for lead plaintiff in a securities fraud case against Galena Biopharma, Inc. .

Today's Dead Cat Bounce Stock: Galena Biopharma (GALE)
The Street 03/31 05:49 ET

Trade-Ideas LLC identified Galena Biopharma (GALE) as a "dead cat bounce" (down big yesterday but up big today) candidate

{{article.title}} {{article.title}}
{{article.source}} {{article.time}}

{{article.summary}}

Get News for
Advertisement

Recent Quotes

Symbol Price Chg Chg % Market Cap
GALE 2.29 +0.21 +10.10% 269.94M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.